House of Commons
Part IX of the drug tariff
EDM #306
Tabled 18 March 2020
2019-21 Session
That this House notes that several thousand of residents in each Parliamentary constituency use medical devices and catheters successfully to manage urinary incontinence and maintain quality of life; welcomes the significant decreases in deaths through improvements in medical devices and catheterisation techniques; acknowledges that those improvements have been underpinned by Part IX of the Drug Tariff which provides fixed prices for safe and effective products; supports the long-standing policy that clinicians have the right and duty to prescribe products on that list are most appropriate for each patient; further notes the introduction of large numbers of more limited lists of products through local formularies and frameworks by NHS trusts, care commissioning groups and NHS Supply Chain; notes that those lists often fail to emphasise the importance of clinician access to the full range of products on Part IX, undermining clinical freedom and patient choice and putting a strain on the NHS through avoidable admissions for urinary tract infections; and calls on the Secretary of State for Health and Social Care to make a commitment to Part IX of the Drug Tariff and to ensure that NHS England complies with formularies and frameworks for continence products in relation to Part IX of the Drug Tariff.

Signatures (8)

The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.
In addition to the sponsors, the following Members have signed to support the motion.
There are no withdrawn signatures for this Motion